We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.9B
AUM Growth
+$1.47B
Cap. Flow
+$1.54B
Cap. Flow %
14.16%
Top 10 Hldgs %
12.66%
Holding
527
New
158
Increased
123
Reduced
88
Closed
149

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$163M
2
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$132M
3
AGN
Allergan plc
AGN
+$129M
4
DVN icon
Devon Energy
DVN
+$117M
5
EA
Electronic Arts
EA
+$115M

Top Sells

Rank Stock Value
1
PCP
PRECISION CASTPARTS CORP
PCP
+$93.6M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$89.6M
3
XRX icon
Xerox
XRX
+$87.3M
4
ZTS icon
Zoetis
ZTS
+$82M
5
CFG icon
Citizens Financial Group
CFG
+$75.4M

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 14.81%
3 Industrials 13.15%
4 Financials 12%
5 Consumer Discretionary 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHO icon
326
Sunstone Hotel Investors
SHO
$2.06B
$2.02M 0.02%
+144,639
New +$1.78M
NVCN
327
DELISTED
Neovasc Inc.
NVCN
$2M 0.02%
19
– –
UDR icon
328
UDR
UDR
$12.3B
$1.97M 0.02%
+50,989
New +$1.82M
BSFT
329
DELISTED
BroadSoft, Inc.
BSFT
$1.96M 0.02%
+48,653
New +$1.65M
KRC icon
330
Kilroy Realty
KRC
$4.42B
$1.95M 0.02%
+31,533
New +$1.77M
NVRO
331
DELISTED
NEVRO CORP.
NVRO
$1.95M 0.02%
+34,617
New +$2.04M
ATYR
332
aTyr Pharma
ATYR
$50.1M
$1.93M 0.02%
35,054
+12,978
+59% +$987K
CPHD
333
DELISTED
Cepheid Inc
CPHD
$1.91M 0.02%
57,297
-1,123,752
-95% -$35.3M
VRTS icon
334
Virtus Investment Partners
VRTS
$1.1B
$1.84M 0.02%
+23,547
New +$2.12M
NWHM
335
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$1.84M 0.02%
150,000
-46,668
-24% -$470K
MIC
336
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1.82M 0.02%
+27,024
New +$1.71M
INNL
337
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$1.81M 0.02%
210,972
– –
ELDN icon
338
Eledon Pharmaceuticals
ELDN
$285M
$1.77M 0.02%
1,949
+395
+25% +$388K
GGP
339
DELISTED
GGP Inc.
GGP
$1.67M 0.02%
+56,169
New +$1.54M
BPMC
340
DELISTED
Blueprint Medicines
BPMC
$1.66M 0.02%
91,837
+17,556
+24% +$305K
SLG icon
341
SL Green Realty
SLG
$3.99B
$1.65M 0.02%
+17,585
New +$1.61M
ACGN
342
DELISTED
Aceragen Inc
ACGN
$1.64M 0.02%
6,099
+1,198
+24% +$320K
GNCA
343
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.63M 0.02%
26,313
+5,831
+28% +$185K
XLRN
344
DELISTED
Acceleron Pharma
XLRN
$1.58M 0.01%
+60,000
New +$1.74M
EVDY
345
DELISTED
Everyday Health, Inc.
EVDY
$1.5M 0.01%
267,315
+8,265
+3% +$40.7K
GNMK
346
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.46M 0.01%
276,398
+8,544
+3% +$47.6K
CATY icon
347
Cathay General Bancorp
CATY
$4.24B
$1.43M 0.01%
+50,308
New +$1.39M
GATX icon
348
GATX Corp
GATX
$6.27B
$1.39M 0.01%
+29,306
New +$1.25M
TBCH
349
Turtle Beach Corp
TBCH
$277M
$1.35M 0.01%
295,784
+186,221
+170% +$932K
CLR
350
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.19M 0.01%
39,177
-1,004,975
-96% -$22.7M
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2016 Portfolio in Review

As of Q1 2016, Alyeska Investment Group held 527 positions worth $10.9B, up 16% from $9.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $1.54B of net new capital in Q1 2016, opening 158 new positions and adding to 123 existing holdings. Its largest new stake was Bausch Health: 2,200,000 shares worth $57.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amdocs, an estimated $66.8M trimmed.

  • Alyeska Investment Group's largest Q1 2016 buy was Bausch Health: 2,200,000 shares worth $57.9M.
  • Alyeska Investment Group added most to Devon Energy in Q1 2016, an estimated $117M increase.
  • Alyeska Investment Group's biggest Q1 2016 reduction was Amdocs, cutting an estimated $66.8M.
  • Alyeska Investment Group fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $93.6M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $10.9B portfolio in Q1 2016.
  • Alyeska Investment Group opened 158 new positions and closed 149 in Q1 2016.
  • Alyeska Investment Group's portfolio value rose 16% quarter-over-quarter to $10.9B.

Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.